Sartorius presents new premium mechanical pipette Tacta
Responding to the needs of users in the laboratories, Sartorius presents a new range of mechanical pipettes with a perfectly balanced design offering reliability, accuracy and comfortable use.
Now available from Sartorius, the Tacta range of premium mechanical pipettes. Tacta has perfectly balanced design that it is easy, safe and comfortable to use. Tacta meets the most demanding pipetting requirements, delivering consistent and accurate results time after time. Manufactured from carefully selected materials, each component is designed to meet the highest standards of comfort and reliability. The new pipettes are available in a range of volumes from 0.1 to 10,000 µL in single channel models, and from 0.5 to 300 µL in multichannel models.
Tacta’s ergonomic and clever design enables extremely low pipetting and tip ejection forces that reduce the risk of Work Related Upper Limb Disorder (WRULD). The unique handle and finger hook design let the pipette rest lightly in the user’s hand, with no need to grip the handle tightly, providing reliable and accurate results during lengthy pipetting sessions. The new Sartorius Optiject, levered tip ejection technology, enables controlled and smooth tip ejection with minimum force. The Optiload feature, with spring-loaded tip cones in both single and multi-channel models, ensures tip loading with perfect sealing and minimal force.
In addition, the new Sartorius Optilock system provides flexible volume adjustment and locking functionalities, and prevents accidental volume changes during pipetting. Tacta has a large, clear 4-digit display, which makes the volume easy to read even when the pipette is at an angle. Furthermore, Tacta is very easy to adjust for a variety of liquids, using a simple adjustment key. An integrated adjustment functionality and scale show the degree of adjustment and, by noting this value for a specific liquid, the user can return to that setting any time.
With only three parts to disassemble and requiring no tools, Tacta pipettes are particularly quick and easy to clean. They can also be autoclaved without disassembly and are highly resistant to exposure to UV and chemicals. In addition, Safe-Cone Filters are available for all Tacta models with volumes of more than 10 µL and offer a cost-effective method to reduce contamination. The unique Safe-Cone Filter ejector enables easy removal of used or contaminated filters without human contact. All Tacta pipettes are fully compatible with original Sartorius “Optifit” and “SafetySpace” pipette tips, enabling maximum accuracy and precision.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.